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Induction of Somatic Mutation
in a Human B Cell Line In Vitro
Ste´phane Dene´poux,* Diane Razanajaona,* apoptosis (Han et al., 1995; Pulendran et al., 1995a;
1995b; Shokat and Goodnow, 1995). Several features ofDominique Blanchard,* Genevie`ve Meffre,*
the hypermutation machinery have been described: (1)J. Donald Capra,† Jacques Banchereau,*
an intrinsic nucleotide sequence preference (Golding etand Serge Lebecque*
al., 1987; Betz et al., 1993), (2) a DNA strand polarity*Schering-Plough Laboratory for
(Lebecque and Gearhart, 1990), (3) the ability to targetImmunological Research
sequences other than IgV genes (Azuma et al., 1993;69571 Dardilly Cedex
Yelamos et al., 1995), (4) the transcription dependenceFrance
(Sablitzky et al., 1985; Peters and Storb, 1996), and (5)†Molecular Immunology Center
the requirement of several cis-acting elements (Betz etDepartment of Microbiology
al., 1994). However, the precise surface trigger(s) asSouthwestern Medical Center
well as the intracellular molecular mechanisms remainUniversity of Texas
unknown, partly because of the absence of a well-Dallas, Texas 75235-9140
defined in vitro model.
Activation of normal mouse B cells with anti-MHCII
antibodies (Wysocki et al., 1992) or LPS (Manser, 1987)Summary
leads to their proliferation and isotype switch, but not
to somatic mutation. In the human, CD40 and surfaceBoth the B cell–surface trigger(s) and the intracellular
immunoglobin cross-linking in the presence of IL-4 in-molecular mechanism(s) of somatic hypermutation in
duces sIgD1 naive tonsillar B cells to proliferate andimmunoglobulin (Ig) variable region genes remain un-
switch isotype, butnot to accumulate somatic mutationsknown, partly because of the lack of a simple and
(Galibert et al., 1995). Induction of somatic mutation inreproducible in vitro model. Here, we show that upon
vitro was first observed (Decker et al., 1995) after re-surface immunoglobulin cross-linking followed by co-
peated antigenic stimulations of mouse memory B cellsculture with activated cloned T cells, the Burkitt’s lym-
cultured on splenic fragment cultures, an experimentphoma cell line BL2 is induced to mutate its IgVH gene. that demonstrated that memory B cells could reenterRepeated activation of BL2 cells increased the fre-
the germinal center reaction to undergo de novo somaticquency of mutation. The in vitro–induced mutations,
mutations. Recently, somatic mutations triggered in vivowhich do not affect the IgM constant region, are point
by mouse immunization could be sustained in vitro whenmutations distributed over the entire VHDJH gene seg- splenic fragments were replaced by an activated T cell
ment and do not show evidence of antigen-driven se-
clone (Kallberg et al., 1996). We determined that a frac-
lection.
tion of FACS-sorted sIgD1 naive tonsillar B cells could
be induced to mutate their IgV genes upon culturing
Introduction with anti-CD3–activated human TH2-cloned T cells (Ra-
zanajaona et al., submitted). However, the polyclonality
The affinity maturation of T cell–dependent antibody of the B cells makes the system difficult to analyze and
responses results from the accumulation of point muta- therefore does not provide a simple screening assay
tions in the variable (V) region of immunoglobulin (Ig) for the identification of the cellular trigger(s) of somatic
genes, followed by antigen-driven selection of the B mutation.
lymphocytes expressing high affinity antibodies (for re- We therefore tested whether a clonal human B cell
views, see Gray, 1993; MacLennan, 1994b; Liu and line could likewise be induced to mutate in vitro. To
Banchereau, 1996; Wagner and Neuberger, 1996). This date, the few B cell lines that have been shown to un-
process takes place in secondary lymphoid organs, in dergo somatic mutation in vitro mutate spontaneously
the highly specialized microenvironment of the germinal in the absence of any specific trigger. In particular, the
center (GC) (Berek et al., 1991; Jacob et al., 1991; Kall- murine B cell line 18.81 (Wabl et al., 1989) has been
berg et al., 1993; Kuppers et al., 1993; McHeyzer Wil- used as a recipient for the reversion of a stop codon in
liams et al., 1993; MacLennan, 1994a; Pascual et al., a transfected VH template to study the DNA elements
1994; Ziegner et al., 1994). T cells are required for the required for somatic mutation (Green et al., 1995; Zhu
formation of germinal centers and the activation of so- et al., 1995). Additionally, a low rate of spontaneous
matic hypermutation (Han et al., 1995; Kelsoe, 1995; mutations has been reported in a human follicular lym-
Miller et al., 1995). Their contribution, through the inter- phoma (Wu et al., 1995). We have selected a type I
actions between CD40 and its ligand as well as B7–2 Burkitt’s lymphoma cell line as it is the closest immortal-
and CD28/CTLA-4 (Han et al., 1995), appears to operate ized counterpart of germinal center centroblasts. The
in a dose-dependent fashion (Miller et al., 1995). B cells presence of somatic mutation in immunoglobin VH genes
are believed to undergo hypermutation at the centro- of Burkitt’s lymphomas has confirmed their germinal
blast stage (Pascual et al., 1994) followed by selection center origin (Chapman et al., 1995; Klein et al., 1995).
at the centrocyte stage via interactions with follicular The type I Burkitt’s lymphoma cell line BL2 does not
dendritic cells in a process leading to survival of high carry the EBV genome, it expresses an IgM/l antibody,
affinity clones (Liu et al., 1989). Negative selection of and it has features of centroblastic B cells. We report
here that surface immunoglobin cross-linking followedautoreactive B cellsor low affinity clones occurs through
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by coculture with activated cloned T cells induces BL2 shown to be identical, with the same rate of background
mutations (not shown). This result further confirmed thecells to accumulate somatic mutation in their IgVH genes.
stability of BL2 cells in culture.
Results
Anti-IgM Triggering and T Cell–Mediated
Signals Do Not Change the GrowthBL2 Is a Centroblastic Germinal Center B
Cell Line and Phenotype of BL2 Cells
BL2 cells were incubated for 30 min at 48C with an anti-The homogeneity and the stability of BL2 cells in bulk
cultures were established through phenotypic and im- IgM antibody, washed, and cultured for seven days at
50 or 500 cells per well over 2.5 3 104 T cells of themunoglobin gene analysis. BL2 cells express sIgM (Fig-
ure 1A) but not sIgD, IgG, or IgA (not shown). They CD41 FS35 clone that were activated with immobilized
anti2CD3 antibody. Similar levels of thymidine incorpo-express the GC-specific B cell markers CD10 and CD38
and the centroblastic marker CD77 (Liu et al., 1994; ration at days 3 and 7 and identical viable cell numbers
at day 7 were observed when BL2 cells were culturedPascual et al., 1994) but are negative for CD44, a marker
expressed on resting B cells. Consistent with a previous alone or cocultured with T cells, thus indicating that
surface immunoglobin cross-linking and coculture withreport that describes Burkitt’s lymphomas as Fas-nega-
tive tumors (Moller et al., 1993), BL2 cells do not express activated FS35 T cells did not modify their proliferation
rate. After seven days, the cocultures yielded 4,100–CD95/fas. BL2 cells express intracytoplasmic Bcl-2,
most probably in relation to its transformed status. 8,800 B cells when 50 B cells were seeded and 49,000–
55,000 B cells when 500 B cells were seeded. A flowMonoclonality of the BL2 cell line was confirmed by the
exclusive expression of a surface l chain and of a unique cytometry analysis of the cells performed after four days
of coculture did not reveal any anti-IgM– or T cell–VH4DJH5-Cm transcript, as proven by PCR, using a series
of leader (L) VH family–specific primers (Marks et al., induced phenotypic alterations of the markers studied
in Figure 1A (data not shown).1991) and a Cm-specific primer (not shown). Consistent
with the flow cytometry analysis, neither d, g, a, nor e
transcripts could be detected after PCR amplification
(not shown). After cloning the LVH4-Cm PCR product, BL2 Cells Introduce Somatic Mutations in Their
IgVH Gene After Surface Immunoglobinrandomly picked colonies all yielded the same variable
region (VDJ) sequence composed of a mutated VH4–39 Cross-Linking and Coculture with
Activated TH2-Cloned T Cellsgene segment (Sanz et al., 1989; van der Maarel et al.,
1993) (Figure 1B) rearranged to an undefined DH segment After seven days of culture, both activated and nonacti-
vated BL2 cells were harvested and total RNA was ex-and a mutated JH5 joining segment. Assuming that the
published VH4–39 sequence is identical to the germline tracted and reverse transcribed. At the end of the cocul-
ture with T cells, LVH4-Cg transcripts could not begene sequence in the patient from which the BL2 cell
line derives, 22 somatic mutations are present in the amplified, indicating that this culture condition did not
induce BL2 cells to isotype switch towards IgG (dataVH4–39 sequence, and two differences at the VHDJH junc-
tion have probably been introduced during gene recom- not shown) while normal naive sIgD1 B cells would have
switched isotype (Kelly et al., 1992). In nonactivatedbination. The high number of somatic mutations sug-
gests that, in agreementwith the centroblast phenotype, BL2 cells, a 40 cycle PCR amplification with Pfu DNA
polymerase yielded 3 mutations in 30 VDJ (420 bp) se-BL2 results from the transformation of a germinal center
centroblast that has undergone several rounds of so- quences that correspond to a frequency of 2.4 3 1024
mut.bp21. Similarly, two mutationswere found in 30 CH1-matic mutations, though it has not switched isotype.
The background level of mutations observed in BL2 Cm constant region sequences (290 bp), what corre-
sponds to a frequency of 2.3 3 1024 mut.bp21 (Figurebulk cultures was established with RNA extracted from
5000 cells (a number of cells similar to what was ob- 2A). In contrast, 15 mutations were found in the VDJ of
30 LVH4-CH1-Cm sequences from activated BL2 cellstained at the end of BL2 / T cells coculture; see below).
The LVH4-Cm was PCR amplified with Pfu DNA polymer- (Figure 2B). These 15 mutations represent 11.9 3 1024
mut.bp21, a 5-fold increase over the background (p ,ase, and a total of 80 VDJ sequences were analyzed.
Eight independent mutations, found in eight sequences, 0.01). A third of the sequences were mutated with a
mean of 1.5 mutations per mutated sequence. Two ofrepresent a background level of 8 / (80 3 420) 5 2.4 3
1024 mutation per total sequenced base pair (mut.bp21) the mutated sequences (SD800 and SD807) (Figure 2B)
shared one mutation and had each accumulated another(or 1 mutation in 4200 sequenced base pairs). BL2 cells
were maintained in culture during the course of the pres- mutation. In contrast, only a background level of muta-
tion was found in the constant region of the coculturedent study, and VDJ transcripts were sequenced before
and after 30 passages (corresponding to two months of cells. The three mutations found in 30 sequences of the
CH1-Cm exon are not statistically different from the twoculture and approximately 60 cell divisions) and were
Figure 1. The Burkitt’s Lymphoma Cell Line BL2 Displays Features of Centroblasts
(A) The phenotypes of BL2 and purified human germinal center B cells are compared using FACS analysis.
(B) The VH sequence of the IgM expressed in BL2 is compared to the VH4–39 germline sequence. Upper case indicates replacement mutations;
lower case, silent mutations.
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Figure 2. BL2 Cells Are Induced To Mutate Their IgVH Genes after Surface Immunoglobin Cross-Linking and Coculture with Activated Cloned
T Cells
(A and B) Thirty LVH4-CH1Cm sequences from BL2 cells (seeded at 50 cells per well) cultured for 7 days in medium alone (A) or after activation
through surface immunoglobin cross-linking and coculture with activated FS35 T cells (B) are schematically illustrated. The three CDRs are
overlined. CH1-Cm represents the first 290 base pairs of the IgM constant region. Silent mutations are depicted as vertical bars and replacement
mutations are depicted as bars topped with a black filled circle. Shared mutations are squared.
(C and D) Clonal trees have been deduced from the VDJ sequences derived from a single well after one round of surface immunoglobin cross-
linking and coculture with activated FS35 T cells and after seeding 500 or 50 cells per well, respectively. Shared mutations are indicated by
arbitrary numbers.
mutations observed in 30 sequences from nonactivated Similar mutation rates were observed in eight cocul-
ture wells from three independent experiments per-cells (p . 0.05). Thus, mutations were restricted to the
VDJ region without affecting the CH1-Cm. formed over a period of 15 months. Altogether, a total
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Induction of Somatic Mutation in BL2 Cells
Requires Both Surface Immunoglobin
Cross-Linking and Activated T Cells
Coculture of BL2 cells with activated FS35 cells without
cross-linking of sIgM did not induce somatic mutation
as, in two independent cocultures, a background level
of mutations was found in the VDJ of BL2 cells cocul-
tured for seven days with anti-CD3–activated FS35 cells
(Figure 3). Of note, the absence of IgM-mediated signal
did not lead BL2 cells to undergo apoptosis upon cocul-
ture with activated FS35 cells as it has been reported
for BL2 cells in cocultures with Jurkat T cells (Schattner
et al., 1996). Indeed, the same number of living BL2 cells
was observed at the end of the coculture with or without
Figure 3. Surface Immunoglobin Cross-Linking and Activated T
prior surface IgM cross-linking. Moreover, consistentCells Are Both Necessary and Sufficient for the In Vitro Induction
with the same report (Schattner et al., 1996), CD95 ex-of Somatic Mutation in BL2 Cells
pression was induced on the surface of BL2 cells uponThe frequency of somatic mutation in the IgVH gene segment of BL2
coculture with CD40 ligand expressing fibroblasts (notcells is displayed as the mean, for all the analyzed wells, of the
number of mutations observed per total VDJ base pairs analyzed shown) but not after four or seven days of coculture
for each well. The left panel indicates the activation with or without with activated FS35 cells with or without prior surface
an anti-IgM antibody and the culture with or without FS35 or MT9 IgM cross-linking of BL2 cells (not shown).
T cells in anti-CD3 precoated wells. The right panel indicates the Likewise, surface immunoglobin cross-linking of BL2
numbers of wells and clones analyzed for each culture condition.
cells followed by culture in medium alone induced nei-The frequency of mutations in the CH1-Cm constant region in 60
ther somatic mutation (Figure 3) nor apoptosis of BL2sequences (displayed in Figures 2A and 2B) is 2.3 3 1024 mut.bp21.
cells (not shown).
of 530 clones were analyzed either by direct sequencing Repeated Activation of BL2 Cells Increases
or after temperature gradient gel electrophoresis (TGGE) the Frequency of Somatic Mutations
analysis (not shown) followed by sequencing. The level In order to increase the frequency of somatic mutation,
of mutation was comparable whether 50 or 500 BL2 the same protocol of activation was repeated four times.
cells were seeded at the beginning of the coculture. A At days 0, 4, 7, and 10, cells were collected, incubated
mean of 26% of the sequences were mutated with a for 30 min with the anti-IgM antibody, and washed. Then
mean of 1.6 mutations per mutated sequence (Figure 50 cells were either cultured in medium alone (Figure
3), which leads to a frequency of 9.6 3 1024 mut.bp21 4A) or seeded over freshly harvested FS35 T cells in
(6 2.5 SD), corresponding to a 4-fold increase over the anti-CD3–coated wells. After 14 days, cells were har-
background (p , 0.01). In five out of eight wells, se- vested for extraction of RNA and VDJ sequence analysis.
quences sharing mutations were found. In one of them As shown in Figure 4C, 40% of the VDJ sequences
(Figure 2C), three sequences were clonally related, re- were mutated with a mean of 2.8 mutations per mutated
spectively bearing one, two, and three mutations. In sequence, a frequency of 27.0 3 1024 mut.bp21, corre-
another well, a genealogical tree was constructed with sponding to an 11.3-fold increase over the background
five sequences (Figure 2D) derived from 48 sequences mutation level (p , 0.01). In cells collected after a 4
after seeding 50 BL2 cells over activated FS35 T cells. day coculture (Figure 4B), 26% of the sequences were
These trees show that somatic mutations accumulated mutated with a mean of 1.25 mutations per mutated
during cell division in this system. Absence of mutations sequence, and this frequency of mutations was also
in the constant region, multiple mutations found per found when the cells were collected at day 14 after only
mutated sequence, and clonal relatedness of the mu- one activation (data not shown). Two sequences from
tated sequences demonstrate that somatic mutation is day 4 (Figure 4B; SDA326 and SDA330) carry mutations
induced in BL2 upon surface immunoglobin cross-link- also found in sequences (Figure 4C; SDA266 and
ing and coculture with activated T cells. SDA270) from the cells of the same well activated 4
times and cultured for 14 days. Moreover, at day 14
(Figure 4C), two of the sequences (SDA263 and SDA274)Activated TH1-Cloned T Cells Can Also Induce
Somatic Mutation in Anti-IgM–Activated were clonally related, sharing two mutations. In a parallel
experiment, coculture of activated BL2 cells with MT9BL2 Cells
The TH1 human T cell clone MT9 could substitute for cells instead of FS35 cells (Figure 4D) led to the same
increase in the frequency of somatic mutation. After twothe TH2 clone FS35 as cross-linking of sIg followed by
one week of coculture on activated MT9 cells yielded weeks of coculture, 33% of the VDJ sequences were
mutated with a mean of 2.8 mutations per mutated se-25% of mutated sequences with a mean of 1.3 mutation
per mutated sequence. The frequency of somatic muta- quence. In contrast, in all the wells analyzed, the CH1-
Cm constant region remained unmutated (Figure 4D).tion induced by MT9 cells (Figure 3) was statistically
different (p , 0.05) from the background but not from Consistent with previous experiments (Figure 3), multi-
ple activation of BL2 cells did not lead to induction ofthe frequency of mutations induced with FS35 cells
(p . 0.05). somatic mutation in theabsence of either T cells (Figures
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Figure 4. Multiple Rounds of Activation of BL2 Cells Increase the Frequency of Somatic Mutation Induced In Vitro
BL2 cells were submitted at days 0, 4, 7, and 10 to surface Ig cross-linking and culture in medium alone (A) or over a fresh layer of anti-
CD3–activated FS35 T cells. Cells were collected at day 4 (B) or at day 14 (A and C) for RNA extraction and sequence analysis after direct
sequencing of cloned VDJ-CH1-Cm PCR products. Symbols are as in Figure 2. Sequences indicated by (a) or (b) share one mutation. The
number of mutations per total sequenced base pairs (D) is displayed as in Figure 3. Additionally, the number of activations is indicated on
the side of the left panel. The frequency of mutations in the CH1-Cm constant region in the 45 sequences displayed in (A), (B), and (C) is 2.3 3
1024 mut.bp21.
4A and 4D) or anti-IgM triggering (Figure 4D). These sic hot spots for somatic mutations are found 13 times
experiments confirmed that somatic mutations accumu- in the VDJ of BL2, and nine of them are mutated. These
lated during cell division since a genealogical tree of AGT/C sites, which represent 8.5% of the VDJ size,
five mutated sequences (Figure 5) could be constructed account for 26% of the mutations. The distribution of
from 30 sequences obtained after two weeks of cocul- the mutationsbetween thedifferent framework and CDR
ture with MT9 cells. regions (Table 1) is roughly correlated to the size of
these regions, with no obvious bias for the CDRs. More-
Analysis of the Somatic Mutations Induced over, the R/S ratio analysis shows no bias for replace-
In Vitro in BL2 Does Not Show Evidence ment mutations, with the exception of CDR1, which may
of Antigen-Driven Selection be due to the base composition of this region (Chang
Altogether, 240 mutations were detected out of a total and Casali, 1994).
of 590 clones analyzed. Mutations occurring at the same All of the mutations introduced in vitro in BL2 cells
position were considered as independent mutations are substitutions, as neither insertion nor deletion was
only when they appeared in different wells. Since the
observed. Notably, none of the 152 independent substi-
background level of mutation represents less than one
tutions leads to a stop codon. Consistent with previousfifth of the mutations observed, all of the independent
reports (Neuberger and Milstein, 1995; Wagner et al.,mutations have been included for an overall analysis of
1995; Smith et al., 1996), the mutations (Table 2) showtheir nature. Out of 240 mutations, 152 were indepen-
a bias for transition over transversion (1.5/1), and theydent mutations distributed over 101 positions (Figure
preferentially affect pyrimidines (57% of the mutations).6). This compilation shows that themutations aredistrib-
Such biases are intrinsic features of somatic mutationuted over the entire VDJ segment with some accumula-
occurring in vivo (Neuberger and Milstein, 1995; Wagnertion over a few hot spots. In particular, the serine at
et al., 1995; Smith et al., 1996). Altogether, the naturecodon 31 represents a hot spot as observed in vivo in
and the localization of the mutations induced in vitronumerous other VL and VH gene segments (Neuberger
and Milstein, 1995; Smith et al., 1996). The AGT/C intrin- in BL2 VDJ gene segments are comparable to those
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Figure 5. Clonal Accumulation of Mutations
in BL2 Cells Activated In Vitro
Five mutated sequences were found to be
clonally related among 30 sequences ob-
tained from the same well after four rounds
of activation of BL2 cells in presence of MT9.
The sequences are displayed (A) as in Figure
1B and the genealogical tree (B) was con-
structed as in Figures 2C and 2D.
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Figure 6. The Somatic Mutations Induced In
Vitro Are Distributed over the Entire IgVH Gene
The 152 independent mutations observed in
the VDJ of BL2 cells were compiled. Identical
mutations are reported as independent muta-
tions only if they appeared in separate culture
wells. Upper case indicates replacement mu-
tations; lower case, silent mutations.
identified in the somatic mutations that are occurring in utive activations, which represents one mutation every
vivo in the absence of antigen-driven selection. 408 base pairs sequenced. The background level (2.4 3
1024 mut.bp21) was established by sequencing 34800
Discussion base pairs of the constant region CH1-Cm exon from
activated and nonactivated BL2 cells and 33600 base
pairs of VDJ from bulk-cultured, nonactivated BL2 cells.Surface Immunoglobin Cross-Linking Followed
by Coculture with Activated T Cells Induces This rate of mutation can be attributed to the errors
incorporated successively by the reverse transcriptaseBL2 Cells to Accumulate Bona Fide
Somatic Hypermutations and by the DNA polymerase, since it is the same in the
IgV gene and in the CH1-Cm exon. (2) The presence ofFour independent experiments, summarized in Table 3,
demonstrated that the type I Burkitt’s lymphoma cell clonally related sequences allowed the construction of
genealogical trees, which indicated that the mutationsline BL2 accumulates mutations in its IgV gene upon
cross-linking of its surface IgM and subsequent cocul- had accumulated along cell division. (3) The localization
of the mutations observed is characteristic of somaticture with activated CD41–cloned T cells. These muta-
tions correspond to somatic hypermutations for the fol- mutations found in vivo (Neuberger and Milstein, 1995;
Smith et al., 1996). They are restricted to the IgV genelowing reasons. (1) The frequency of mutation in the IgV
genes of activated BL2 cells is significantly higher than and preferentially accumulated over the previously de-
scribed hot spot Ser31 and AGT/C consensus motif. (4)the background level. Upon surface immunoglobin
cross-linking and coculture with activated T cells, the The distribution of the base substitution is similar to that
previously reported in vivo for IgV genes. Despite a slightfrequency of mutations in BL2 IgV genes was 9.6 3 1024
mut.bp21 (four times higher than the background level) and unexplained bias for the substitution of G and C
bases, the replacement pattern is strictly identical to(p , 0.01) after one activation and rose to 24.5 3 1024
mut.bp21 (11.2 times higher) (p , 0.01) after four consec- what has been described earlier for each nucleotide
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Table 2. Distribution of Base Substitutions Induced in BL2 CellsTable 1. Somatic Mutations Induced in BL2 Cells In Vitro Do Not
Accumulate Preferentially in CDRs In Vitro
% of Total % of Total To T C A G n Corrected
Domain R/S Mutations Size
From
T — 0.50 0.25 0.25 9 0.07L .4 3 15
FR1 1.1 25 24 C 0.66 — 0.08 0.26 57 0.36
A 0.27 0.27 — 0.46 12 0.11CDR1 14.0 10 6
FR2 0.6 14 11 G 0.09 0.32 0.59 — 74 0.46
CDR2 0.6 16 13
The table shows the distribution of 152 independent base substitu-FR3 2.0 24 26
tions, on the coding strand, as the proportion of the total for eachCDR3 0.5 2 7
base, along with the number of each base affected (n). The correctedFR4 9.0 6 15
proportions show the distribution of each affected nucleotide after
Total FR 1.4 71 75 correction forbase composition sinceT, C, A, and G bases represent
Total CDR 1.4 29 25 respectively 23%, 29%, 19%, and 29% of the VDJ of BL2.
Distribution of 152 independent somatic mutations affecting 101
positions of the VDJ of BL2 cells.
1986). After processing of this antigen, B cells are
thought to receive T cell help from antigen-specific
helper T cells (MacLennan, 1994a). In vivo, those centro-(Neuberger and Milstein, 1995; Smith et al., 1996). More-
over, A bases are replaced 1.6 times more often than T blasts have been shown to actively mutate their IgV
genes (Kuppers et al., 1993; Pascual et al., 1994). Simi-bases, which is in agreement with strand polarity of the
machinery described for somatic mutation. (5) Neither larly, induction of somatic mutations in BL2 in vitro re-
quired both membrane immunoglobin-mediated and TVH-to-VH recombination, gene conversion, nor reciprocal
recombination would result in the stepwise accumula- cell–derived signals. A single and short exposition to an
anti-IgM antibody was sufficient for the induction oftion of up to five new mutations distributed over the
VHDJH, with conservation of the preexisting mutations somatic mutation. Preliminary data suggested that
longer exposures for up to 24 hours at 378C, prior toin BL2 cells. Altogether, the highly significant frequency
of mutations, their restriction to the IgV gene, their coculture with activated T cells, did not yield a higher
mutation frequency (not shown). However, the progres-clonal-relatedness, their localization, and their nature
established that the mutations induced in vitro in BL2 sive accumulation of mutations after repeated sIg acti-
vation is consistent with themodel (Kepler and Perelson,cells are bona fide somatic hypermutations.
1993) in which B cells undergo several cycles of somatic
mutations through multiple passages within germinalIn Vitro–Induced Somatic Mutations Show
That BL2 Cells Are Not Submitted centers.
T cell–derived signal(s) were provided equally well byto Antigen-Driven Selection
Somatic mutations induced in vitro are distributed over either TH1- or TH2-cloned T cells. The two T cell clones
exhibit different cytokine expression patterns. There-the entire VDJ. They do not accumulate preferentially
within the CDRs, and their R/S ratios are low in both fore, if T cell cytokines are necessary for the induction
of somatic mutation in BL2 cells, these cytokines eitherFRs and CDRs. This suggests that BL2 cells were free of
IgVH-mediated selective pressure in this culture system. are shared by the two clones or have redundant activi-
ties, as suggested by reconstitution experiment in aHowever, no stop codon was observed in 152 indepen-
dent mutations, suggesting that the loss of immuno- mouse model (Rizzo et al., 1992). Regarding cell surface
molecules, both T cell clones express the CD40L uponglobin expression may somewhat affect the rate of divi-
sion or even the survival of BL2 cells. This is reminiscent anti-CD3 activation, but CD40/CD40L interaction is not
sufficient to trigger somatic mutation in naive B cells inof a previous report showing that sIg expression is re-
quired for the clonal expansion of follicular lymphoma vitro (Galibert et al., 1995). In the absence of specific
antigen and because BL2 cells are most unlikely to trig-cells invivo (Miller et al., 1982). However, the observation
that 17% of the sequences from one culture well seeded ger alloreaction in both FS35 and MT9 T cells, BL2 cells
probably did not require stimulation through their MHCwith 50 BL2 cells (Figure 5) was clonally related after
four activations with anti-IgM and MT9 cells suggested molecules to mutate their immunoglobulin VH gene.
Moreover, the absence of TcR–MHC interaction doesthat some selection operated during the culture inde-
pendently of any antigen-driven process. not exclude direct contact between BL2 and T cells
through other surface molecules such as B-7/CD28 or
CD27/CD70, the role of which as trigger for somaticAntigen Receptor and T Cell–Mediated Signals
Mimic Part of the GC Reaction and Are mutation is presently being investigated. However, all
the signals provided to the Bcells during the GC reactionSufficient for Inducing Somatic
Mutation in BL2 Cells were probably not available in this culture system since,
even after repeated activation, only a third of BL2 cellsGerminal center Bcells receive immunoglobin-mediated
signals upon encounter with the antigen displayed at mutated and these accumulated only up to five muta-
tions. Moreover, activation through sIg cross-linking andthe surface of follicular dendritic cells (Liu et al., 1996)
and/or of dendritic cells (Grouard et al., 1996), in the coculture with activated T cells did not induce BL2 cells
to switch isotype.Whether this inability toswitch isotypeform of immune complexes (MacLennan and Gray,
Immunity
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Table 3. Compilation of the Results from Four Independent Experiments
Culture Conditions1 Mutations2
Percentage of Frequency of Mutations per
Rounds of mutated VHDJH mutations mutated Mode of
B Cells Anti-IgM T Cells Activation sequences (31024) sequence n Analysis
Bulk 5000 2 2 0 10 2.4 1.00 80 i
Control Figure 2A 50 2 2 1 10 2.4 1.00 30 iii
Experiment 1 Figure 2C 500 1 FS35 1 25 7.9 1.38 65 i
500 1 FS35 1 10 3.5 1.45 106 ii
Figure 2B 50 1 FS35 1 33 11.7 1.50 30 iii
37 14.9 1.73 90 ii
Figure 2D 50 1 FS35 1 38 17.6 2.00 48 ii
Experiment 2 500 1 FS35 1 19 8.0 1.63 32 ii
500 1 FS35 1 37 9.7 1.85 24 ii
500 1 2 1 9 2.0 1.00 23 ii
500 2 FS35 1 8 1.9 1.00 24 ii
Experiment 3 50 1 FS35 1 16 7.8 1.51 50 i
50 1 FS35 1 22 6.7 1.30 45 i
50 1 MT9 1 25 7.6 1.30 40 i
50 1 2 1 10 2.4 1.00 20 i
50 2 FS35 1 8 1.9 1.00 25 i
Experiment 4 Figure 4B 50 1 FS35 1 26 7.8 1.25 15 iii
Figure 4C 50 1 FS35 4 40 27.0 2.83 15 iii
Figure 5 50 1 MT9 4 33 22.1 2.81 30 i
Figure 4A 50 1 2 4 8 1.6 1.00 15 iii
50 2 FS35 4 9 1.9 1.00 45 i
Individual lanes represent separate wells. Figure number in which the sequences are diplayed is indicated.
1 BL2 cells were either incubated with (1) or without (2) an anti-IgM monoclonal antibody and seeded at 50 or 500 cells per well in medium
alone (2) or over fresh FS35 or MT9 CD41 cloned T cells in anti-CD3–coated wells. The cells were either cocultured for seven days (1) or
activated four times over two weeks (4). In this case, cells were collected at days 4, 7, and 10; incubated with or without the anti-IgM antibody;
and seeded in medium alone or over freshly collected T cells. One well was analyzed in part at day 4 (Figure 4B) and at day 14 (Figure 4C).
2 The frequency of mutations is the number of mutations divided by the total number of base pairs sequenced. The number of mutations per
mutated sequence is the mean for each well. Sequences were analyzed either after a LVH4-Cm PCR amplification, by direct sequencing of
randomly picked colonies (i) or after TGGE screening and sequencing of the mutated clones (ii), or after LVH4-CH1-Cm PCR amplification,
including the first exon of the IgM constant region, and direct sequencing of randomly picked colonies (iii). In the case of TGGE analysis
preceding the sequencing of mutated clones, the total number of base pairs was calculated. The total number of clones analyzed (n) is
indicated for each analysis.
San Diego, CA); and CD83 (HB15a; kindly provided by Zhou andis specific for BL2 cells or would also apply to normal
Tedder).memory sIgM1 B cells remains presently unknown.
In conclusion, the induction of somatic mutation in
T Cellsthe human B cell line BL2 requires both B cell–receptor
FS35 is a CD41 T cell clone derived from an allergic patient that
and T cell–mediated signals. The sIg cross-linking can recognizes Derp1, the major allergen from Dermatophagoides pte-
be brief, but repeated activations increase the frequency ronyssinus (Parronchi et al., 1991). FS35 is a TH2-like clone that,
of mutations. Moreover, T cell signals can be provided upon activation, secretes large amounts of IL4 and IL10 and only
small amounts of IL2 and IL5. The CD41 T cell clone MT9 wasequally well by a TH1 or a TH2 clone. This is a simple
derived from phytohemagglutinin (PHA)-stimulated peripheral bloodand reliable system to identify the trigger(s) of somatic
lymphocytes (PBL) of a healthy donor (Hermann et al., 1993). Uponhypermutation and should facilitate the understanding
activation, MT9 secretes large amounts of IL2 and gIFN but noof the molecular mechanisms involved.
detectable IL4 or IL10, making it a human TH1-like T cell clone
(Blanchard et al., 1994).
Experimental Procedures The T cell clones were expanded in DMEM F12 medium supple-
mented with 10% horse serum and 1% Caryoser. They were stimu-
BL2 Cell Line and GC B Cells lated weekly with a feeder cell mixture containing irradiated periph-
The BL2 cell line was established from a tumor biopsy obtained eral blood mononuclear cells, 0.1 mg/ml phytohemagglutinin (PHA),
from a caucasian child. It is negative for the EBV genome and has
and recombinant IL2. The cells were used 7 days after their last
a t(8; 22) (q24; q11) reciprocal translocation (Cohen et al., 1987). It
activation by feeder cells.was cultured in DMEM F12 medium supplemented with 10% horse
serum and 1% Caryoser (IBF, Sepracor, Baltimore, MD). GC cells
Cocultureswere isolated from tonsillar B cells by negative selection using
For the coculture of T and B cells, flat bottom 96-well culture platesCD39- and IgD-specific antibodies as described (Liu et al., 1994).
were coated with a 1:1000 dilution of the OKT3 anti-CD3 antibody
(ATCC, Rockville, MD) for 2 hr at room temperature. FS35 T cellsFACS Analysis
were irradiated with 4000 rads and seeded at 2.5 3 104 cells perThe phenotype of BL2 and GC cells was analyzed with a Becton-
well in 100 ml of the same culture medium. BL2 cells were incubatedDickinson FACS Scan using a series of monoclonal and polyclonal
with a soluble monoclonal anti-human IgM completeantibody (Jack-antibodies to CD20, CD71, and CD80 (Becton-Dickinson, San Jose,
son, West Grove, Pennsylvania) for 30 min at 48C. The cells wereCA); CD10, CD23, CD38, CD39, CD77, and CD95 (Immunotech, Mar-
then washed and seeded at 50 or 500 cells per well in a 100 mlseille, France); CD44 (Sigma, Saint Lois, MO); Bcl-2, IgM, and IgD
volume of the same culture medium, alone or over the activated T(Dako, Glostrup, Denmark); IgG (Kallestad, Austin, TX); k and l im-
munoglobin light chains (Ortho, Raritan, NJ); CD86 (Pharmingen, cells.
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